|
1）Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006; 113: 1799-806
|
|
|
|
2）Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002; 39: 1113-9
|
|
|
|
|
|
3）Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002; 39: 930-6
|
|
|
|
|
|
4）McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv. 2006; 67: 335-43
|
|
|
|
|
|
5）Morcos SK, Thomsen HS; European Society of Urogenital Radiology. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging. 2003; 28: 187-90
|
|
|
|
|
|
6）Mehta RL, Kellum JA, Shah SV, et al; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11: R31
|
|
|
|
|
|
7）Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008; 73: 1008-16
|
|
|
|
|
|
8）Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidney injury. J Am Soc Nephrol. 2011; 22: 810-20
|
|
|
|
|
|
9）KDIGO Clinical Practice Guideline for Acute Kidney Injury, Online Appendics A-F: 68-76. (http: //www. kdigo. org/clinical_practice_guidelines/AKI. php)
|
|
|
|
|
|
10）Perrin T, Descombes E, Cook S. Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly. 2012; 142: w13608
|
|
|
|
|
|
11）Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008; 23: 2151-57
|
|
|
|
|
|
12）日本腎臓学会, 編．CKD診療ガイド2012. 東京: 東京医学社; 2012. p.18-21
|
|
|
|
|
|
13）Rickli H, Benou K, Ammann P, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004; 61: 98-102
|
|
|
|
|
|
14）Briguori C, Visconti G, Rivera NV, et al. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010; 121: 2117-22
|
|
|
|
|
|
15）Nakamura T, Sugaya T, Node K, et al. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006; 47: 439-44
|
|
|
|
|
|
16）Manabe K, Kamihata H, Motohiro M, et al. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest. 2012; 42: 557-63
|
|
|
|
|
|
17）Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115: 610-21
|
|
|
|
|
|
18）Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin(NGAL)as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365: 1231-8
|
|
|
|
|
|
19）Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007; 22: 2089-95
|
|
|
|
|
|
20）Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, et al. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail. 2009; 31: 910-9
|
|
|
|
|
|
21）Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004; 43: 405-14
|
|
|
|
|
|
22）Ling W, Zhaohui N, Ben H, et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract. 2008; 108: c176-81
|
|
|
|
|
|
23）Hudzik B, Szkodzinski J, Danikiewicz A, et al. Serum interleukin-6 concentration predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Eur Cytokine Netw. 2010; 21: 129-35
|
|
|
|
|
|
24）Chertow GM, Normand SL, McNeil BJ. ‘‘Renalism’’: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol. 2004; 15: 2462-8
|
|
|
|
|
|
25）菅谷 健，木村健二郎．AKI早期診断のための尿バイオマーカーパネル. 医学のあゆみ. 2009; 231 (2): 154-7
|
|
|
|